Vinodh Kakkassery
Overview
Explore the profile of Vinodh Kakkassery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Engelmann K, Kakkassery V, Stolze G, Weidner J, Sedlmayr M
Ophthalmologie
. 2025 Jan;
PMID: 39775876
No abstract available.
2.
Stolze G, Kakkassery V, Kowerko D, Bartos M, Hoffmann K, Sedlmayr M, et al.
Ophthalmologie
. 2024 Dec;
PMID: 39692888
Background: Evidence-based treatment recommendations are helpful in the corresponding discipline-specific treatment but can hardly take data from real-world care into account. In order to make better use of this in...
3.
Varghese J, Schuster A, Poschkamp B, Yildirim K, Oehm J, Berens P, et al.
JMIR Med Inform
. 2024 Dec;
12:e60851.
PMID: 39637381
The EyeMatics project, embedded as a clinical use case in Germany's Medical Informatics Initiative, is a large digital health initiative in ophthalmology. The objective is to improve the understanding of...
4.
Lang B, Balermpas P, Bauer A, Blum A, Dirschka T, Follmann M, et al.
J Dtsch Dermatol Ges
. 2024 Nov;
22(12):1697-1714.
PMID: 39584658
Basal cell carcinoma is the most common malignant tumor in the fair-skinned population and its incidence continues to rise. An update of the S2k guideline with the participation of all...
5.
Holtrup L, Varghese J, Schuster A, Poschkamp B, Hampf C, Waltemath D, et al.
Ophthalmologie
. 2024 Nov;
PMID: 39542916
The evaluation of real-world data (RWD) enables insights to be gained from a wide range of patient data collected in routine clinical practice. In addition, multicenter analyses represent a broad...
6.
Hoffmann K, Peng Y, Schlosser T, Stolze G, Langner H, Susky M, et al.
Stud Health Technol Inform
. 2024 Sep;
317:139-145.
PMID: 39234716
Introduction: Seamless interoperability of ophthalmic clinical data is beneficial for improving patient care and advancing research through the integration of data from various sources. Such consolidation increases the amount of...
7.
Chlad P, Kakkassery V, Wolf A, Miller C, Strauss O, Alfaar A
Ophthalmic Epidemiol
. 2024 Jul;
32(2):187-196.
PMID: 38968083
Purpose: This study aims to evaluate the epidemiological patterns, treatment strategies, and survival outcomes of conjunctival malignancies in Germany between 2009 and 2019. Methods: A total of 1,532 cases were...
8.
Tura A, Zhu Y, Vardanyan S, Prasuhn M, Kakkassery V, Luke J, et al.
Invest Ophthalmol Vis Sci
. 2024 Jun;
65(6):7.
PMID: 38833258
Purpose: The purpose of this study was to analyze the extent of DNA breaks in primary uveal melanoma (UM) with regard to radiotherapy dose delivery (single-dose versus fractionated) and monosomy...
9.
Kakkassery V, Heindl L
Ophthalmologie
. 2024 May;
121(5):350-351.
PMID: 38720095
No abstract available.
10.
Liu Y, Rokohl A, Muller M, Kakkassery V, Fan W, Heindl L
Ophthalmologie
. 2024 May;
121(5):366-373.
PMID: 38700760
Orbital and periocular metastatic tumors used to be considered very rare; however, with the constant updating of drugs and detection methods for cancer treatment, new chemotherapies and radiation treatments are...